Sale!

MFN2 Gene CMT2A2 Genetic Test

4,400 د.إ

-21%

The MFN2 gene is associated with Charcot-Marie-Tooth disease type 2A2 (CMT2A2), a condition characterized by the degeneration of peripheral nerves that primarily affects the muscles and sensory systems of the body. The MFN2 gene plays a crucial role in the maintenance and function of these nerves. Mutations in the MFN2 gene disrupt these processes, leading to the symptoms observed in individuals with CMT2A2, including muscle weakness, decreased muscle size, sensory loss, and in some cases, foot deformities.

The MFN2 Gene CMT2A2 Genetic Test is a specialized diagnostic tool used to identify mutations in the MFN2 gene that are responsible for CMT2A2. This test is essential for confirming the diagnosis, understanding the prognosis, and guiding the management and treatment strategies for individuals suspected of having CMT2A2. Additionally, the test can be valuable for family planning decisions for those with a history of the condition.

Conducted at DNA Labs UAE, a leading facility in genetic testing, the test ensures high accuracy and reliability. The cost of the MFN2 Gene CMT2A2 Genetic Test is 4400 AED. This price reflects the comprehensive nature of the test, covering the analysis, interpretation, and reporting conducted by experienced geneticists. The test results can provide crucial insights into the genetic basis of the condition, enabling personalized care and management plans for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MFN2 Gene CMT2A2 Genetic Test

At DNA Labs UAE, we offer the MFN2 Gene CMT2A2 Genetic Test for individuals suspected of having Charcot-Marie-Tooth disease type 2A2 (CMT2A2). This hereditary neurological disorder affects the peripheral nerves and is characterized by muscle weakness and wasting, particularly in the feet and lower legs, as well as sensory loss in the affected areas.

Test Details

The MFN2 gene is associated with CMT2A2. Our NGS (next-generation sequencing) technology allows us to analyze the MFN2 gene for mutations that may cause CMT2A2. This comprehensive genetic testing method can detect a wide range of genetic variations in a single test, making it an invaluable tool for diagnosing and managing genetic disorders.

Test Components and Price

  • Components: Blood or Extracted DNA or One drop Blood on FTA Card
  • Price: 4400.0 AED

Sample Condition

We accept blood samples, extracted DNA, or one drop of blood on an FTA Card for this test.

Report Delivery

After the sample is received, the test results will be delivered within 3 to 4 weeks.

Test Type

This test falls under the category of Neurological Disorders.

Doctor and Test Department

This test is conducted by our experienced neurologists in our Genetics department.

Pre Test Information

Prior to undergoing the MFN2 Gene CMT2A2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with MFN2 Gene CMT2A2.

Treatment and Management

If a mutation is identified in the MFN2 gene, genetic counseling may be recommended to discuss the implications of the test results and provide guidance on managing the condition. Treatment for CMT2A2 may include physical therapy, orthotics, and other supportive measures to manage symptoms and improve quality of life.

Test Name MFN2 Gene CMT2A2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MFN2 Gene CMT2A2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MFN2 Gene CMT2A2
Test Details

The MFN2 gene is associated with Charcot-Marie-Tooth disease type 2A2 (CMT2A2), which is a hereditary neurological disorder affecting the peripheral nerves. CMT2A2 is characterized by muscle weakness and wasting, particularly in the feet and lower legs, as well as sensory loss in the affected areas.

NGS (next-generation sequencing) genetic testing can be used to analyze the MFN2 gene for mutations that may cause CMT2A2. This type of testing is able to detect a wide range of genetic variations in a single test, making it a valuable tool for diagnosing and managing genetic disorders.

If a mutation is identified in the MFN2 gene, genetic counseling may be recommended to discuss the implications of the test results and to provide guidance on managing the condition. Treatment for CMT2A2 may include physical therapy, orthotics, and other supportive measures to manage symptoms and improve quality of life.